Samson Terefe Kassa
J. Agri. Res. Adv., 01 (04):27-47
Samson Terefe Kassa: Addis Ababa University, Ethiopia
Article History: Received on: 04-Nov-19, Accepted on: 17-Dec-19, Published on: 30-Dec-19
Corresponding Author: Samson Terefe Kassa
Email: terefe.samson@yahoo.com
Citation: Kassa ST (2019). Review on the epidemiology and public health importance of Marburg Hemorrhagic Fever in Africa. J. Agri. Res. Adv., 01 (04):27-47
Marburg
virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe,
often fatal illness in humans. Rousettus aegyptiacus, fruit bats of the Pteropodidae
family, are considered to be natural hosts of Marburg virus. The Marburg virus
is transmitted to people from fruit bats and spreads among humans through
human-to-human transmission. The Marburg virus causes severe viral haemorrhagic
fever in humans. The average MVD case fatality rate is around 50%. Case
fatality rates have varied from 24% to 88% in past outbreaks depending on virus
strain and case management. Community engagement is key to successfully
controlling outbreaks. Good outbreak control relies on applying a package of
interventions, namely case management, infection prevention and control
practices, surveillance and contact tracing, a good laboratory service, safe
burials and social mobilization. Early supportive care with rehydration, symptomatic
treatment improves survival. There is as yet no licensed treatment proven to
neutralize the virus but a range of blood, immunological and drug therapies are
under development. Marburg virus belongs to the genus Marburg virus in the family
Filoviridae and causes a severe hemorrhagic fever, known as Marburg hemorrhagic
fever (MHF), in both humans and nonhuman primates. Similar to the more widely
known Ebola hemorrhagic fever, MHF is characterized by systemic viral
replication, immunosuppression and abnormal inflammatory responses. These
pathological features of the disease contribute to a number of systemic
dysfunctions including hemorrhages, edema, coagulation abnormalities and,
ultimately, multiorgan failure and shock, often resulting in death. A detailed
understanding of the pathological processes that lead to this devastating
disease remains elusive, a fact that contributes to the lack of licensed
vaccines or effective therapeutics. This article will review the clinical
aspects of MHF and discuss the pathogenesis and possible options for diagnosis,
treatment and prevention.
Copyrights © 2013 All Rights Reserved Journal Of Agricultural Research Advances (JARA)
Developed by: Object Developer | Software Company Udaipur